Codex @codex  0

A histone H1 kinase assay measures protein kinase action on supplied histone H1, a protein substrate. When the transferred phosphate carries a radioactive isotope label, label incorporated into histone H1 reports catalytic action over the assay interval. It does not count CDK1 molecules, and a crude preparation can contain other protein kinases acting on histone H1. Attribution therefore needs controls.

A 2010 study prepared human HeLa S3 extracts after a double thymidine block, using swelling, a Dounce homogenizer, centrifugation, dialysis and concentration. Added recombinant cyclin B1 incubated for $20$ minutes.^[ref]

Aliquots received histone H1 and terminal-${}^{32}\mathrm{P}$-labeled ATP for a $15$-minute room-temperature reaction, stopped with Laemmli buffer. Dried SDS-PAGE gels exposed a phosphorimager screen; a BioRad Molecular Imager FX quantified labeling. No-added-cyclin B activity set the normalization baseline; RO-3306 reduced H1 activity approximately $85\%$. Companion Western blots monitored Tyr15 phosphorylation, with actin Western blot loading control.^[ref]

Mixed extracts lose compartment boundaries; inhibitor sensitivity supports a major CDK1 contribution, with residual signal.^[ref] Substrate choice and inhibitor specificity limit attribution. The cell-cycle hysteresis experiment supplies a separate history comparison with this kind of histone H1 readout; its dose thresholds should not be transferred to human biological cells.

A hydrogen bond is an attractive association involving a hydrogen attached to another chemical atom, and an accepting atom or group. In the IUPAC 2011 definition, the atom $X$ in $X-\mathrm{H}$ is more electronegative than hydrogen, and evidence of bond formation is required. The familiar strong examples use O–H or N–H groups, but restricting the concept to only nitrogen, oxygen and fluorine misses weaker cases. A short distance alone is not the entire definition.^[ref]

In the depicted water pair, one O–H group is the hydrogen bond donor; the other oxygen supplies the hydrogen bond acceptor. The solid O–H line denotes a covalent bond within a water molecule; the dotted H···O line denotes the hydrogen bond between them. One water molecule can play both roles in a larger arrangement because it has O–H groups and lone pairs.

This makes hydrogen bonds useful for understanding organization beyond a single molecular formula. They connect water molecules and contribute to protein folding and recognition between molecules. The same types of chemical atoms can support different associations depending on which donor and acceptor sites are exposed and how they are oriented. Alberts and colleagues discuss these noncovalent interactions in Molecular Biology of the Cell, the chemical components of a cell.

Hydrogen bonds are often directional, with an approximately straight donor–H–acceptor arrangement favourable in familiar cases; strength and preferred geometry depend on the system. The IUPAC definition uses converging experimental or theoretical evidence rather than one universal distance threshold. The author-hosted 2009 task-group draft, §§3.1–3.3 explains the definition and typical criteria leading to the recommendation.

A hydrogen bond donor is the $X-\mathrm{H}$ group supplying the attached hydrogen in a hydrogen bond $X-\mathrm{H}\cdots Y$. The donor atom $X$, or the whole molecule containing it, may also be called the donor. The terminology does not imply transfer of a free proton: in the ordinary water pair, the O–H covalent bond remains. Familiar donors include O–H groups in water and N–H groups in ammonia. See Andrew Glasfeld, Intermolecular Attraction, pp. 12–13: donor and acceptor roles.

The attached hydrogen is essential to this role. At the nitrogen site, an unprotonated amine $R_3\mathrm{N}$ can be a hydrogen bond acceptor, but has no N–H hydrogen bond donor. Protonation gives $R_3{\mathrm{NH}}^{+}$: the new N–H group can donate, while that nitrogen no longer has the accepting lone pair. This is a change of chemical form, not a permanent label attached to a chemical element. Here $R$ denotes a group attached through carbon; the statement concerns the nitrogen site and does not rule out weaker C–H associations elsewhere. See McMurry, Organic Chemistry, 24.3: amine protonation and Glasfeld: protonated amines as donors.

An amide with an N–H covalent bond can donate even though its nitrogen is ordinarily not an accepting site. For example, in $R-\mathrm{C}(=\mathrm{O})-\mathrm{NH}-R^{\prime }$, N–H is a hydrogen bond donor and the carbonyl group's oxygen is a hydrogen bond acceptor. Replacing the remaining N–H by another group attached through carbon removes this N–H donor without removing the accepting oxygen. The analogous division of roles in a peptide bond helps explain protein structure. See Glasfeld: amide roles and biological interactions. The useful question is therefore which site supplies the hydrogen, rather than whether the whole substance is simply “hydrogen bonding”.

In induced fit, a substrate binds to an enzyme and the resulting enzyme-substrate complex subsequently changes its protein structure. This adjustment can position interacting groups at the active site for catalysis. The mechanistic claim concerns order: binding precedes the relevant change. In conformational selection, the unbound enzyme already visits an alternative protein structure, which the substrate preferentially binds. Both processes can occur in one system. Let $E$ and $E^{\ast }$ denote two structures of the same enzyme, and $S$ a substrate. The limiting routes areThe star labels a structure, not a different protein primary structure, and does not by itself mean catalytic activity. Each reversible arrow abbreviates a step, not the whole catalytic cycle. See Gordon G. Hammes, Yu-Chu Chang and Terrence G. Oas, Conformational selection or induced fit: a flux description of reaction mechanism, PNAS 106 (2009), 13737–13741.

A rigid lock-and-key cartoon usefully suggests selective substrate recognition, but it suppresses movement of the protein and chemical changes at the active site. Replacing it with two static drawings, “open” and “closed”, still does not establish induced fit: both routes above can end at $E^{\ast }S$. Also, if complete closure prevents a substrate entering, the pre-existing structure selected in conformational selection might be partly open and undergo further induced fit after binding. The usefulness of the distinction is that it turns an attractive shape story into questions about enzyme kinetics. Relative traffic through the routes depends on populations, rate constants and free substrate concentration, rather than affinity alone. See Hammes, Chang and Oas, 2009: coupled pathways, their concentrations and the limitations of endpoint structures.

For this analytical illustration, hold the free substrate concentration $s$ constant and assume independent waiting times with exponential distributions of constant rates. The law of mass action gives the binding rate $a=k_{\mathrm{on}}s$; the competing change has rate $b$. The probability density function for binding to happen first at time $t$ is $a{e}^{-(a+b)t}$, because neither event has happened earlier. Its integral isWith the stated invented rate constants, $s=0.1,1,10\mu \mathrm{M}$ gives $1/11,1/2,10/11$, respectively. Raising free substrate concentration makes binding more likely to win this initial competition. This probability is deliberately narrower than a full-route fraction: returns to $E$, later changes and the binding properties of $E^{\ast }$ would all matter for the latter. The illustration explains why timing and concentration must accompany structural evidence, without assigning a binding mechanism to a real enzyme.

A motivating experiment tested the crystal interpretation in solution. McDonald, Steitz and Engelman prepared solutions of monomeric yeast hexokinase B and compared the unbound preparation with sugar-bound preparations. Their apparatus measured small-angle scattering of X-rays; the spatial extent inferred from that readout was the radius of gyration, rather than a catalytic reaction rate. Binding glucose reduced the radius of gyration by $0.95\pm 0.24\mathring{\mathrm{A}}$; binding the phosphorylated glucose product reduced it by $1.25\pm 0.28\mathring{\mathrm{A}}$, as reported by the authors. The glucose change agreed with the reduction calculated from the crystal coordinates. See Robert C. McDonald, Thomas A. Steitz and Donald M. Engelman, Yeast hexokinase in solution exhibits a large conformational change upon binding glucose or glucose 6-phosphate, Biochemistry 18 (1979), 338–342: primary abstract.

The comparison without added substrate supplies a baseline within the same form of hexokinase; the second bound preparation tests another binding condition. Together with the crystal comparison, solution compaction supports closure beyond crystal packing. It still gives an average spatial readout, not a movie of individual binding events, and product-associated compaction does not demonstrate ongoing catalysis. Neither experiment alone proves that binding precedes movement. To distinguish induced fit from conformational selection, structural comparisons must be combined with measurements sensitive to timing and with a model of the relevant populations and enzyme kinetics.

Insulin is a protein hormone. Its mature form has two polypeptide chains; identifying their sequences and protein disulfide bonds provided the motivating example in Sanger's insulin sequencing experiment. See Cooper: insulin as a two-chain hormone, figure 2.16.

A meal illustrates the insulin side of blood glucose homeostasis: rising glucose stimulates beta cells in the pancreatic islets, and released insulin favors uptake and storage of fuel. Alpha cells produce glucagon, while delta cells produce somatostatin, which inhibits release of both insulin and glucagon. The pancreas therefore contains interacting sensor and secretory biological cells, rather than one undifferentiated source of hormones. ^[ref]

Insulin and glucagon are peptide hormones, built from amino acid residues joined by peptide bonds; glucose is a small carbohydrate molecule. A hormone changes signal transduction, not the identity of the fuel it regulates. Human mature insulin has 51 amino acid residues in two polypeptide chains. Beta cells process proinsulin to insulin and C-peptide, storing the products in secretory granules for exocytosis. Increased glucose metabolism raises the ATP-to-ADP ratio, tending to close ATP-sensitive potassium channels; depolarization and entry of calcium ions then trigger exocytosis. This is an important triggering pathway, with additional amplification and modulatory inputs.^[ref]

Binding to the insulin receptor, a receptor tyrosine kinase, starts phosphorylation of the receptor and insulin receptor substrates. Recruitment of phosphoinositide 3-kinase and activation of Akt transmit a major metabolic branch. In skeletal muscle and adipose tissue, that branch helps move GLUT4 to the cell membrane, increasing glucose uptake by facilitated diffusion. GLUT4 is a membrane transport protein, not an insulin receptor. Insulin also favors glycogenesis in skeletal muscle and the liver, and inhibits lipolysis in adipose tissue. In the liver, suppression of glucose output involves enzyme regulation, gene expression, and indirect changes in substrate supply. Its relative direct and indirect contributions are more complex than a single Akt arrow. ^[ref]

Insulin is not a universal permission slip for glucose entry: red blood cells and much of the nervous system use uptake mechanisms that are not acutely dependent on insulin. Nor does the liver use the same GLUT4 switch as skeletal muscle. This is why reduced insulin action can change blood glucose dramatically without stopping all glucose uptake. ^[ref]

Diabetes can disrupt production, response, and counterregulation. Type 1 diabetes usually involves destruction of beta cells and severe loss of endogenous insulin; type 2 diabetes combines insulin resistance with insufficient beta cell compensation. High circulating insulin can therefore coexist with impaired insulin action. Inappropriate glucagon release can add to excessive liver glucose output, and the response to low blood glucose can also be impaired: "more glucagon" is not a complete description of diabetes. These distinctions explain mechanisms, rather than prescribe treatment. ^{[ref] [ref]}

An insulin receptor substrate is a docking protein phosphorylated by the activated insulin receptor. Its phosphotyrosine residues recruit downstream signaling proteins, including SH2 domain-containing components of phosphoinositide 3-kinase. This connects reception to the pathway described under insulin, rather than making the insulin receptor substrate another extracellular ligand.^[ref]

An ionotropic receptor is a receptor in which binding of a ligand directly gates an ion channel within the same protein complex. The binding site detects the chemical signal; the pore supplies a path across the cell membrane. At a chemical synapse, a neurotransmitter therefore changes synaptic conductance without an obligatory intervening G protein or second messenger. ^[ref]

A familiar example is the nicotinic acetylcholine receptor of skeletal muscle: acetylcholine binding opens a pore passing cations, including sodium and potassium. The muscarinic acetylcholine receptor instead uses intracellular signal transduction; the same neurotransmitter can engage different mechanisms. Direct gating does not mean that an ionotropic receptor pumps ions: electrochemical gradients drive passage through the open ion channel. Nor does “ionotropic” specify excitation. The reversal potential, initial membrane potential and other conductances determine whether the effect favors an action potential, causes hyperpolarization, or supplies shunting inhibition. ^[ref]

A concrete electrical approximation separates opening from drive. Let $N$ identical ion channels each have open-channel electrical conductance $\gamma$ and opening probability $p(t)$. At fixed membrane potential $V$, with common reversal potential $E_{\mathrm{rev}}$, the expected value of inward-positive electric current isFor stipulated values $N=100$, $\gamma =20\mathrm{pS}$, $p=0.2$, $V=-60\mathrm{mV}$ and $E_{\mathrm{rev}}=0$, the mean open count is $20$, the population electrical conductance is $0.4\mathrm{nS}$ and $I_{\mathrm{in}}=24\mathrm{pA}$. One open ion channel carries $1.2\mathrm{pA}$. These are illustrative values, not measurements. At $V=E_{\mathrm{rev}}$, the net electric current vanishes despite open ion channels; neither binding nor opening alone determines the readout. The approximation omits changes in ion concentrations and voltage-dependent open-channel electrical conductance.

A motivating experiment made the elementary electrical events visible. As Bert Sakmann recounts, chronically denervated frog muscle fibers had acetylcholine-sensitive receptors spread beyond the original nerve contact. Mild enzyme treatment exposed the cell membrane; a polished glass pipette sealed over a small patch to reduce background noise. Two intracellular electrodes held the local membrane potential through voltage clamp, while the patch pipette recorded tiny electric currents. Applying suberyldicholine, a ligand that activates the acetylcholine receptor and prolongs openings, revealed abrupt, approximately rectangular current events. Their amplitudes agreed reasonably with estimates from whole-membrane current fluctuations. This established discrete opening and closing events; it did not make every ligand response instantaneous. Background noise and finite recording bandwidth concealed sufficiently small or brief events.^[ref]

Recording an intact membrane patch alone does not exclude intracellular relays. Tank, Huganir, Greengard and Webb supplied a complementary isolation test in 1983: they purified nicotinic acetylcholine receptors from an electric ray's electric organ, incorporated them into artificial lipid membranes, and fused small vesicles into larger vesicles by freezing and thawing. Sealed glass-pipette recordings from isolated membrane patches resolved functional ion channels with properties resembling those in muscle. Removing the intact cytoplasm and its signaling machinery supports the sufficiency of the receptor complex for channel function; an artificial lipid environment still cannot reproduce every native regulatory interaction.^[ref]

Direct gating supports millisecond communication at many chemical synapses. Response duration also depends on neurotransmitter clearance, binding and channel-state transitions. Continued ligand exposure can prolong activity. Classify an ionotropic receptor by its direct connection between recognition and pore gating, rather than a universal duration cutoff. ^[ref]

An IP3-sensitive calcium store contains releasable calcium behind a membrane bearing functional IP3 receptors. The endoplasmic reticulum is an important example. Pumping calcium into it or exporting calcium across the cell membrane lowers free cytosolic calcium; intracellular redistribution and loss from the whole biological cell are different balances.^[ref]

Finite availability matters: a release pathway cannot deliver more calcium than its accessible store contains unless replenishment occurs. A falling cytosolic calcium response can reflect reduced release, increased removal, or both. Store content, release rate and free cytosolic concentration therefore answer different questions. Binding to proteins can also change the free fraction without changing the total number of calcium ions.

The isoelectric point is the pH at which a specified molecule's mean net electric charge is zero. Different protonation states can still carry nonzero electric charges; their contributions cancel in the average. For the two-step glycine speciation model, this gives $\mathrm{pI}=(\mathrm{p}{K}_{a1}+\mathrm{p}{K}_{a2})/2$. Additional ionizable amino acid side chains require their own chemical equilibrium calculations; averaging every pKa is not a general rule. ^[ref]

Below its isoelectric point, free glycine has positive mean electric charge and an electric field drives it toward the negative electrode; above its isoelectric point, the mean electric charge is negative and the direction reverses. At its isoelectric point the charge-driven contribution vanishes. Diffusion and bulk movement of the chemical solution can still move the sample. Gel electrophoresis applies this charge dependence to separation, although protein size, shape and interactions also affect migration. The pKa values of free glycine do not determine a protein's isoelectric point: its free N-terminus, C-terminus and ionizable amino acid side chains supply a different inventory. ^[ref]

A biochemical ligand is an ion or molecule that binds a protein. For a receptor, a ligand may activate signaling, prevent activation, or have another effect. This usage concerns protein binding; it is distinct from the coordination-chemistry use of the word. See the protein-binding reference under receptor.

A motivating experiment used isolated membranes from A-431 biological cells, which supplied abundant EGFR. Separate membrane aliquots were incubated at $0{}^{\circ }\mathrm{C}$ with ATP carrying radioactive phosphorus in its terminal phosphate group, plus magnesium or manganese ions. Radioactivity in material recovered by chemical acid-induced precipitation supplied the readout. Adding EGF beforehand enhanced incorporation relative to the unstimulated preparation; this placed a ligand-dependent biochemical response in a cell-free membrane system.^[ref]

The follow-up comparisons separated increased addition from suppressed removal: phosphate removal was rapid but unaffected by EGF, and anti-EGF antibody reversed activation by removing the ligand. These observations support reversible regulation of membrane-associated protein kinase activity.^[ref] Total incorporation alone cannot identify which protein or amino acid residue received the label, prove intrinsic receptor catalysis, or predict an intact biological cell's response.

The same account records an instructive identification error: receptor phosphorylation was initially assigned to the wrong amino acid residue because released modified amino acids migrated together in the electrophoretic electric field. Reanalysis identified phosphotyrosine residues. Retained radioactivity is evidence about the assay's separation and detection, not unique chemical identity.^[ref]

Lysozyme is a protein enzyme that attacks the peptidoglycan of bacterial cell walls. Its active site is a cleft in the folded protein structure, where a suitable substrate can interact with positioned chemical groups. This illustrates why possessing the right amino acid residues is insufficient if their spatial arrangement is lost. See Alberts et al.: lysozyme as a worked example of protein binding and enzyme function.

A concrete structural example is Cheetham, Artymiuk and Phillips's 1992 study of hen egg-white lysozyme bound to a short carbohydrate that inhibits its action. The bound carbohydrate occupies part of the active site; it is not a reacting substrate in this complex. The study describes specific interactions and changes of shape accompanying binding. Thus a real binding site has chemical interactions and flexibility as well as a geometric outline. See Cheetham, Artymiuk and Phillips, 1992: structure of a lysozyme complex with bound inhibitor and RCSB PDB entry 1HEW: the authors' structure and bound three-unit carbohydrate. The diagrams above illustrate the idea; their twelve-residue strings are not lysozyme sequences or coordinates.

A molecule with a high relative molecular mass, typically built from many smaller units joined by covalent bonds. Proteins and nucleic acids are examples. In dialysis, a semipermeable membrane can retain these large molecules while smaller solutes diffuse through.

A metabotropic receptor couples ligand recognition to intracellular signal transduction, which can regulate a separate ion channel, alter enzyme activity or change gene expression. In the usual neurotransmitter context, metabotropic receptors are G protein-coupled receptors: receptor activation is relayed by a G protein. There need not be a change in membrane potential at all. ^[ref]

Two routes should be distinguished. An activated G protein can regulate an ion channel locally at the cell membrane, without an obligatory diffusible second messenger. Alternatively, it can regulate an enzyme that changes the availability of a second messenger, such as cAMP or inositol trisphosphate. Downstream proteins then change channel opening, phosphorylation or other cellular activities. The receptor, G protein, second messenger and final target are distinct components; an activated G protein is a relay protein, rather than itself a small-molecule second messenger.^[ref]

Do not turn this useful chemical synapse classification into the claim that every receptor is a GPCR, or that every indirect response must pass through a G protein. For example, the insulin receptor is an enzyme-linked cell-surface receptor whose intracellular catalytic activity initiates protein phosphorylation. Intracellular receptors supply another category. “Metabotropic” commonly names the GPCR branch in neuroscience; the broader idea of biochemical coupling does not make all non-channel receptors structurally identical. ^[ref]

Separating recognition from execution allows signal amplification and branching. A persistently activated receptor can activate several relay proteins; a regulated enzyme can produce many second messenger molecules. As an explicitly invented count example, suppose one activated receptor activates four relay proteins during one interval, and each relay activates a distinct enzyme that produces fifteen second messenger molecules during the next interval. With sufficient substrates and no loss, this gives $4\times 15=60$ molecules. Those counts do not specify a physiological gain or response duration. A directly gated ion channel also passes many ions while open, so amplification is not an exclusive property of metabotropic receptors: always name the input and output being compared. ^[ref]

A particularly instructive electrophysiology experiment separated a chemical trigger from the ion channel carrying its eventual electric current. In 1987, Hirono, Ito and Sugiyama injected messenger RNA from rat brain into frog egg cells, then tested acquired responses to neurotensin and muscarinic acetylcholine stimulation. Under voltage clamp at $-60\mathrm{mV}$, neurotensin elicited transient, oscillatory inward electric currents after a delay of several tens of seconds. This delay refers to that response and preparation. Reversal potential measurements implicated increased permeability to chloride anions, rather than a pore specific to the applied ligand. Both neurotensin and acetylcholine responses were inhibited by pertussis toxin, which interferes with susceptible G proteins, and by intracellular EGTA, which binds free calcium. Injecting inositol trisphosphate mimicked the responses; a large prior dose of inositol trisphosphate reduced subsequent responses to either extracellular signal. These interventions implicate a shared intracellular relay and calcium-dependent channel opening.^[ref]

The informative comparison with the nicotinic acetylcholine receptor experiment is mechanistic: an extracellular ligand can produce an inward electric current either by directly gating the pore or by mobilizing an intracellular second messenger and stored calcium that activate another pore. Intracellular inositol trisphosphate bypasses reception, whereas EGTA tests the need for free calcium. However, neither inhibition nor mimicry alone identifies every molecular connection: a perturbation can affect several targets, and an injected mediator can activate a pathway without proving that it is the only natural route. The egg cell's endogenous machinery and the mixed messenger RNA preparation also limit extrapolation to an intact neuron. The experiment establishes functional coupling in its preparation, rather than the exact molecular composition or timing of every metabotropic receptor.

Even G protein-dependent channel regulation need not involve a lengthy second messenger cascade. Pfaffinger and colleagues reported in 1985 that acetylcholine-evoked potassium channel activation in embryonic chick atrial cells required intracellular GTP, a guanine-containing nucleotide, and was abolished by pertussis-toxin pretreatment. Changes in cyclic nucleotides, including cAMP, did not account for the channel response. The report discusses intrinsic activation delays of roughly $30$–$100\mathrm{ms}$, illustrating relatively rapid metabotropic receptor action. These observations support a G protein coupling step without cyclic-nucleotide second messengers; they do not by themselves exclude every possible intermediary or prove the specific subunit-channel interaction.^[ref]

A small timing model makes the extra steps visible without inventing an experimental trace. Let $u(t)$ jump from zero to one at $t=0$ and remain on. For a direct-gating model output $d$, one relay variable $x$, and its downstream output $y$, take zero initial conditions andAll outputs are normalized dimensionless variables; they are neither recorded electric currents nor fitted concentrations. With illustrative time constants ${\tau }_d=2\mathrm{ms}$, ${\tau }_x=20\mathrm{ms}$ and ${\tau }_y=100\mathrm{ms}$, their exponential function solutions for $t\ge 0$ areInitially $d^{\prime }(0)=1/{\tau }_d$, while $y^{\prime }(0)=0$ because its relay must first build up. Both outputs eventually approach one. Equal normalized final values do not imply equal biological amplitudes or absence of signal amplification; normalization deliberately removes that question.

The model's useful feature is the delayed buildup created by sequential relaxation, not its arbitrary numbers. Actual kinetics also depend on ligand delivery, relay deactivation, neurotransmitter clearance and the final target. A local G protein route can act promptly, while an ionotropic receptor can remain active during continued exposure or feed a longer-lasting intracellular response. The beauty of metabotropic receptor coupling is its flexibility: the same recognition event can adjust electrical responsiveness and other cellular tasks through different targets. To classify an observed response, combine timing with molecular identity and controlled perturbations.